Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase 4 trial of triple antiretroviral maintenance therapy versus dual-therapy simplification for immune recovery in virologically suppressed HIV infection
2016-005226-11Phase 4Active
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of elvitegravir, cobicistat, tenofovir alafenamide, emtricitabine, dolutegravir in human immunodeficiency virus infection (HIV), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Jan 2017; status: active.
02
Drugs
elvitegravircobicistattenofovir alafenamideemtricitabinedolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2016-005226-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005226-11.